Tech Company Financing Transactions

C2N Funding Round

C2N secured a $7 million financing round on 9/26/2024. Investors included Alzheimer's Drug Discovery Foundation and private investors.

Transaction Overview

Company Name
Announced On
9/26/2024
Transaction Type
Venture Equity
Amount
$7,025,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to develop its biomarkers and novel diagnostic technologies.

Company Information

Company Status
Private & Independent
Industry
Real Estate
Mailing Address
4340 Duncan Avenue
St. Louis, MO 63110
USA
Email Address
Overview
C2N is a specialty diagnostics company providing exceptional laboratory services and products in the field of brain health. C2N's high-resolution mass spectrometry-based biomarker products and services are used for: clinical decision-making to improve patient care, including diagnosis and treatment monitoring; maximizing the quality and efficiency of clinical trials that test novel treatments for neurodegeneration; and providing innovative tools to help healthcare researchers better understand novel mechanisms of disease, identify new treatment targets, and conduct important epidemiological studies to improve global public health.
Profile
C2N LinkedIn Company Profile
Social Media
C2N Company Twitter Account
Company News
C2N News
Facebook
C2N on Facebook
YouTube
C2N on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joel Braunstein
  Joel Braunstein LinkedIn Profile  Joel Braunstein Twitter Account  Joel Braunstein News  Joel Braunstein on Facebook
Chief Medical Officer
Justine Coppinger
  Justine Coppinger LinkedIn Profile  Justine Coppinger Twitter Account  Justine Coppinger News  Justine Coppinger on Facebook
Co-Founder
Ilana Fogelman
  Ilana Fogelman LinkedIn Profile  Ilana Fogelman Twitter Account  Ilana Fogelman News  Ilana Fogelman on Facebook
Controller
Rachel Resnick
  Rachel Resnick LinkedIn Profile  Rachel Resnick Twitter Account  Rachel Resnick News  Rachel Resnick on Facebook
Vice President
Sheena Aurora
  Sheena Aurora LinkedIn Profile  Sheena Aurora Twitter Account  Sheena Aurora News  Sheena Aurora on Facebook
Vice President
Daniel Connell
  Daniel Connell LinkedIn Profile  Daniel Connell Twitter Account  Daniel Connell News  Daniel Connell on Facebook
Vice President
John Contois
  John Contois LinkedIn Profile  John Contois Twitter Account  John Contois News  John Contois on Facebook
Vice President
Chris Rathermel
  Chris Rathermel LinkedIn Profile  Chris Rathermel Twitter Account  Chris Rathermel News  Chris Rathermel on Facebook
VP - Customer Service
Brianne Peters
  Brianne Peters LinkedIn Profile  Brianne Peters Twitter Account  Brianne Peters News  Brianne Peters on Facebook
VP - Finance
Tim Reilly
  Tim Reilly LinkedIn Profile  Tim Reilly Twitter Account  Tim Reilly News  Tim Reilly on Facebook
VP - General Counsel
Micah Onixt
  Micah Onixt LinkedIn Profile  Micah Onixt Twitter Account  Micah Onixt News  Micah Onixt on Facebook
VP - Human Resources
Patricia DeSimone
  Patricia DeSimone LinkedIn Profile  Patricia DeSimone Twitter Account  Patricia DeSimone News  Patricia DeSimone on Facebook
VP - Marketing
Joni Henderson
  Joni Henderson LinkedIn Profile  Joni Henderson Twitter Account  Joni Henderson News  Joni Henderson on Facebook
VP - Operations
Ozgur Sensoy
  Ozgur Sensoy LinkedIn Profile  Ozgur Sensoy Twitter Account  Ozgur Sensoy News  Ozgur Sensoy on Facebook
VP - R & D
Matthew Meyer
  Matthew Meyer LinkedIn Profile  Matthew Meyer Twitter Account  Matthew Meyer News  Matthew Meyer on Facebook
VP - R & D
Philip Verghese
  Philip Verghese LinkedIn Profile  Philip Verghese Twitter Account  Philip Verghese News  Philip Verghese on Facebook
VP - R & D
Tim West
  Tim West LinkedIn Profile  Tim West Twitter Account  Tim West News  Tim West on Facebook
VP - Regulatory Affairs
Catherine Regni
  Catherine Regni LinkedIn Profile  Catherine Regni Twitter Account  Catherine Regni News  Catherine Regni on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/26/2024: Mendaera venture capital transaction
Next: 9/27/2024: Cytix venture capital transaction

 

Share this article

 


About Database of VC Transactions

We report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary